Botulinum Toxin Type‐A (BOTOX ^® ) in the Treatment of Occipital Neuralgia: A Pilot Study

Abstract

Our results indicate that BTX-A improved the sharp/shooting type of pain most commonly known to be associated with occipital neuralgia. Additionally, the quality of life measures assessing burden and long-term impact of the headaches, further corroborated improvement seen in daily head pain.